Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 48291901000001114 | Noxafil (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 48292001000001118 | Noxafil | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Noxafil | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Noxafil 40mg/ml oral suspension (Merck Sharp & Dohme (UK) Ltd) | Is a | True | Noxafil | Inferred relationship | Existential restriction modifier | |
| Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd) | Is a | True | Noxafil | Inferred relationship | Existential restriction modifier | |
| Noxafil 300mg/16.7ml concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) | Is a | True | Noxafil | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR